Search research articles
Contact Us
Filters
Showing results (51-60 of 218) with videos related to
Page
of 22
Sort By:
Targeted Oncology
|
March 15, 2022
Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer
Ping Fan, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Chemoprevention of breast cancer: a model for change
V Craig Jordan, Monica Morrow
Menopause (New York, N.Y.)
|
August 8, 2013
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
Ifeyinwa Obiorah, V Craig Jordan
The Breast Journal
|
May 12, 2001
RESPONSE
Monica Morrow, V. Craig Jordan
Cancer Drug Resistance (Alhambra, Calif.)
|
December 10, 2019
New insights into acquired endocrine resistance of breast cancer
Ping Fan, V Craig Jordan
Journal of the National Cancer Institute
|
May 8, 2003
Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999
V Craig Jordan, Monica Morrow
Advances in Experimental Medicine and Biology
|
July 22, 2008
Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance
Surojeet Sengupta, V Craig Jordan
International Journal of Oncology
|
January 1, 2010
Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells
Jing Peng, V Craig Jordan
JAMA Oncology
|
November 18, 2017
Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer
Balkees Abderrahman, V Craig Jordan
Cancer Journal (Sudbury, Mass.)
|
May 20, 2022
Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures
Balkees Abderrahman, V Craig Jordan
Page
of 22
Search research articles
Search
Showing results (51-60 of 218) with videos related to
Sort By:
Page
of 22
Targeted Oncology
|
March 15, 2022
Estrogen Receptor and the Unfolded Protein Response: Double-Edged Swords in Therapy for Estrogen Receptor-Positive Breast Cancer
Ping Fan, V Craig Jordan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 5, 2002
Chemoprevention of breast cancer: a model for change
V Craig Jordan, Monica Morrow
Menopause (New York, N.Y.)
|
August 8, 2013
Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
Ifeyinwa Obiorah, V Craig Jordan
The Breast Journal
|
May 12, 2001
RESPONSE
Monica Morrow, V. Craig Jordan
Cancer Drug Resistance (Alhambra, Calif.)
|
December 10, 2019
New insights into acquired endocrine resistance of breast cancer
Ping Fan, V Craig Jordan
Journal of the National Cancer Institute
|
May 8, 2003
Re: Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999
V Craig Jordan, Monica Morrow
Advances in Experimental Medicine and Biology
|
July 22, 2008
Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance
Surojeet Sengupta, V Craig Jordan
International Journal of Oncology
|
January 1, 2010
Expression of estrogen receptor alpha with a Tet-off adenoviral system induces G0/G1 cell cycle arrest in SKBr3 breast cancer cells
Jing Peng, V Craig Jordan
JAMA Oncology
|
November 18, 2017
Rethinking Extended Adjuvant Antiestrogen Therapy to Increase Survivorship in Breast Cancer
Balkees Abderrahman, V Craig Jordan
Cancer Journal (Sudbury, Mass.)
|
May 20, 2022
Estrogen for the Treatment and Prevention of Breast Cancer: A Tale of 2 Karnofsky Lectures
Balkees Abderrahman, V Craig Jordan
Page
of 22